[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Monoclonal Antibody Based Products Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

January 2020 | 133 pages | ID: M3783C9EE9C0EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY


Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Monoclonal Antibody Based Products market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Monoclonal Antibody Based Products market segmented into
  • Murine
  • Chimeric
  • Humanized
  • Human
Based on the end-use, the global Monoclonal Antibody Based Products market classified into
  • Therapeutics
  • Diagnostics
Based on geography, the global Monoclonal Antibody Based Products market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Amgen
  • BD Biosciences
  • Biogen Idec
  • Biotest
  • CMC ICOS Biologics
  • Dendreon
  • Elan Corporations
  • Eli Lilly and Company
  • Genentech
  • Human Genome Sciences
  • Immunomedics
  • Johnson & Johnson
  • Centocor
  • Ortho Biotech Products
  • Medarex
  • MedImmune
  • PDL BioPharma
  • Schering-Plough
  • Strategic Diagnostics
  • UCB
  • Wyeth Pharmaceuticals
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL MONOCLONAL ANTIBODY BASED PRODUCTS INDUSTRY

2.1 Summary about Monoclonal Antibody Based Products Industry
2.2 Monoclonal Antibody Based Products Market Trends
  2.2.1 Monoclonal Antibody Based Products Production & Consumption Trends
  2.2.2 Monoclonal Antibody Based Products Demand Structure Trends
2.3 Monoclonal Antibody Based Products Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Murine
  4.2.2 Chimeric
  4.2.3 Humanized
  4.2.4 Human
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Therapeutics
  4.3.2 Diagnostics

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Murine
  5.2.2 Chimeric
  5.2.3 Humanized
  5.2.4 Human
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Therapeutics
  5.3.2 Diagnostics
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Murine
  6.2.2 Chimeric
  6.2.3 Humanized
  6.2.4 Human
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Therapeutics
  6.3.2 Diagnostics
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Murine
  7.2.2 Chimeric
  7.2.3 Humanized
  7.2.4 Human
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Therapeutics
  7.3.2 Diagnostics
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Murine
  8.2.2 Chimeric
  8.2.3 Humanized
  8.2.4 Human
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Therapeutics
  8.3.2 Diagnostics
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Murine
  9.2.2 Chimeric
  9.2.3 Humanized
  9.2.4 Human
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Therapeutics
  9.3.2 Diagnostics
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Amgen
  10.1.2 BD Biosciences
  10.1.3 Biogen Idec
  10.1.4 Biotest
  10.1.5 CMC ICOS Biologics
  10.1.6 Dendreon
  10.1.7 Elan Corporations
  10.1.8 Eli Lilly and Company
  10.1.9 Genentech
  10.1.10 Human Genome Sciences
  10.1.11 Immunomedics
  10.1.12 Johnson & Johnson
  10.1.13 Centocor
  10.1.14 Ortho Biotech Products
  10.1.15 Medarex
  10.1.16 MedImmune
  10.1.17 PDL BioPharma
  10.1.18 Schering-Plough
  10.1.19 Strategic Diagnostics
  10.1.20 UCB
  10.1.21 Wyeth Pharmaceuticals
10.2 Monoclonal Antibody Based Products Sales Date of Major Players (2017-2020e)
  10.2.1 Amgen
  10.2.2 BD Biosciences
  10.2.3 Biogen Idec
  10.2.4 Biotest
  10.2.5 CMC ICOS Biologics
  10.2.6 Dendreon
  10.2.7 Elan Corporations
  10.2.8 Eli Lilly and Company
  10.2.9 Genentech
  10.2.10 Human Genome Sciences
  10.2.11 Immunomedics
  10.2.12 Johnson & Johnson
  10.2.13 Centocor
  10.2.14 Ortho Biotech Products
  10.2.15 Medarex
  10.2.16 MedImmune
  10.2.17 PDL BioPharma
  10.2.18 Schering-Plough
  10.2.19 Strategic Diagnostics
  10.2.20 UCB
  10.2.21 Wyeth Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Monoclonal Antibody Based Products Product Type Overview
2.Table Monoclonal Antibody Based Products Product Type Market Share List
3.Table Monoclonal Antibody Based Products Product Type of Major Players
4.Table Brief Introduction of Amgen
5.Table Brief Introduction of BD Biosciences
6.Table Brief Introduction of Biogen Idec
7.Table Brief Introduction of Biotest
8.Table Brief Introduction of CMC ICOS Biologics
9.Table Brief Introduction of Dendreon
10.Table Brief Introduction of Elan Corporations
11.Table Brief Introduction of Eli Lilly and Company
12.Table Brief Introduction of Genentech
13.Table Brief Introduction of Human Genome Sciences
14.Table Brief Introduction of Immunomedics
15.Table Brief Introduction of Johnson & Johnson
16.Table Brief Introduction of Centocor
17.Table Brief Introduction of Ortho Biotech Products
18.Table Brief Introduction of Medarex
19.Table Brief Introduction of MedImmune
20.Table Brief Introduction of PDL BioPharma
21.Table Brief Introduction of Schering-Plough
22.Table Brief Introduction of Strategic Diagnostics
23.Table Brief Introduction of UCB
24.Table Brief Introduction of Wyeth Pharmaceuticals
25.Table Products & Services of Amgen
26.Table Products & Services of BD Biosciences
27.Table Products & Services of Biogen Idec
28.Table Products & Services of Biotest
29.Table Products & Services of CMC ICOS Biologics
30.Table Products & Services of Dendreon
31.Table Products & Services of Elan Corporations
32.Table Products & Services of Eli Lilly and Company
33.Table Products & Services of Genentech
34.Table Products & Services of Human Genome Sciences
35.Table Products & Services of Immunomedics
36.Table Products & Services of Johnson & Johnson
37.Table Products & Services of Centocor
38.Table Products & Services of Ortho Biotech Products
39.Table Products & Services of Medarex
40.Table Products & Services of MedImmune
41.Table Products & Services of PDL BioPharma
42.Table Products & Services of Schering-Plough
43.Table Products & Services of Strategic Diagnostics
44.Table Products & Services of UCB
45.Table Products & Services of Wyeth Pharmaceuticals
46.Table Market Distribution of Major Players
47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
49.Table Global Monoclonal Antibody Based Products Market Forecast (Million USD) by Region 2021f-2026f
50.Table Global Monoclonal Antibody Based Products Market Forecast (Million USD) Share by Region 2021f-2026f
51.Table Global Monoclonal Antibody Based Products Market Forecast (Million USD) by Demand 2021f-2026f
52.Table Global Monoclonal Antibody Based Products Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Monoclonal Antibody Based Products Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Monoclonal Antibody Based Products Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Monoclonal Antibody Based Products Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Monoclonal Antibody Based Products Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Monoclonal Antibody Based Products Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Monoclonal Antibody Based Products Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Monoclonal Antibody Based Products Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Murine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Chimeric Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Humanized Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Human Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Therapeutics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Monoclonal Antibody Based Products Sales Revenue (Million USD) of Amgen 2017-2020e
72.Figure Monoclonal Antibody Based Products Sales Revenue (Million USD) of BD Biosciences 2017-2020e
73.Figure Monoclonal Antibody Based Products Sales Revenue (Million USD) of Biogen Idec 2017-2020e
74.Figure Monoclonal Antibody Based Products Sales Revenue (Million USD) of Biotest 2017-2020e
75.Figure Monoclonal Antibody Based Products Sales Revenue (Million USD) of CMC ICOS Biologics 2017-2020e
76.Figure Monoclonal Antibody Based Pro


More Publications